Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.
Thrumurthy SG, Thrumurthy SS, Gilbert CE, Ross P, Haji A. Colorectal adenocarcinoma: risks, prevention and diagnosis. BMJ (Clinical Res ed). 2016;354:i3590.
Duraes LC, Steele SR, Valente MA, Lavryk OA, Connelly TM, Kessler H. Right colon, left colon, and rectal cancer have different oncologic and quality of life outcomes. Int J Colorectal Dis. 2022;37(4):939–48.
Google Scholar
Shen H, Yang J, Huang Q, Jiang MJ, Tan YN, Fu JF, et al. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol. 2015;21(21):6470–8.
Google Scholar
Yahagi M, Okabayashi K, Hasegawa H, Tsuruta M, Kitagawa Y. The worse prognosis of Right-Sided compared with Left-Sided Colon cancers: a systematic review and Meta-analysis. J Gastrointest Surgery: Official J Soc Surg Aliment Tract. 2016;20(3):648–55.
Yang CY, Yen MH, Kiu KT, Chen YT, Chang TC. Outcomes of right-sided and left-sided colon cancer after curative resection. Sci Rep. 2022;12(1):11323.
Google Scholar
Yu C, Shi Z, Zhou G, Chang X. Revisiting the survival paradox between stage IIB/C and IIIA colon cancer. Sci Rep. 2024;14(1):22133.
Google Scholar
Li H, Fu G, Wei W, Huang Y, Wang Z, Liang T, et al. Re-Evaluation of the survival paradox between stage IIB/IIC and stage IIIA Colon cancer. Front Oncol. 2020;10:595107.
Google Scholar
Stoffel EM, Murphy CC. Epidemiology and mechanisms of the increasing incidence of Colon and rectal cancers in young adults. Gastroenterology. 2020;158(2):341–53.
Google Scholar
Lichtenstern CR, Ngu RK, Shalapour S, Karin M. Immunotherapy, inflammation and colorectal Cancer. Cells. 2020;9(3):618.
Tokunaga R, Sakamoto Y, Nakagawa S, Miyamoto Y, Yoshida N, Oki E, et al. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal Cancer undergoing primary tumor resection. Dis Colon Rectum. 2015;58(11):1048–57.
Google Scholar
Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261–72.
Google Scholar
Yamamoto T, Kawada K, Obama K. Inflammation-Related biomarkers for the prediction of prognosis in colorectal Cancer patients. Int J Mol Sci. 2021;22(15):8002.
Ding R, Chen Z, He M, Cen H, Liu Z, Su Y. Application value of combined detection of NLR, PNI, D-Dimer, CD3(+) T lymphocytes, and CEA in colorectal Cancer screening. Dis Markers. 2022;2022:7913025.
Google Scholar
Kayikcioglu E, Iscan G. A novel prognostic index for metastatic Colon cancer: the prognostic immune nutritional index. Cureus. 2023;15(1):e33808.
Google Scholar
Liu J, Sun R, Cai K, Xu Y, Yuan W. A nomogram combining neutrophil to lymphocyte ratio (NLR) and prognostic nutritional index (PNI) to predict distant metastasis in gastric cancer. Sci Rep. 2024;14(1):15391.
Google Scholar
Wang J, Liu Y, Mi X, Shao M, Liu L. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics. Annals Palliat Med. 2020;9(3):967–78.
Google Scholar
Zhu J, Wang D, Liu C, Huang R, Gao F, Feng X, et al. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study. Front Immunol. 2023;14:1165510.
Google Scholar
Bolignano D, Mattace-Raso F, Torino C, D’Arrigo G, Abd ElHafeez S, Provenzano F, et al. Prognostic models in the clinical arena. Aging Clin Exp Res. 2012;24(4):300–4.
Google Scholar
Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in Gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–5.
Google Scholar
Mangone L, Pinto C, Mancuso P, Ottone M, Bisceglia I, Chiaranda G, et al. Colon cancer survival differs from right side to left side and lymph node harvest number matter. BMC Public Health. 2021;21(1):906.
Google Scholar
Lee SH, Pankaj A, Neyaz A, Ono Y, Rickelt S, Ferrone C, et al. Immune microenvironment and lymph node yield in colorectal cancer. Br J Cancer. 2023;129(6):917–24.
Google Scholar
Piatto G, Cardin F, Lorenzetti R, Mazzalai F, Militello C, et al. N0 Stage colon cancer: prognostic role of age in relation to tumor site. Aging Clin Exp Res. 2012;24(3 Suppl):2–5. https://pubmed.ncbi.nlm.nih.gov/23160496/.
Kataoka K, Beppu N, Shiozawa M, Ikeda M, Tomita N, Kobayashi H, et al. Colorectal cancer treated by resection and extended lymphadenectomy: patterns of spread in left- and right-sided tumours. 2020;107(8):1070–8.
Michele G, Fausto P, Gianluca TJCTOO. Right Versus Left Colon Cancer: Resectable Metastatic Disease. 2018;19(6):31.
Groth SS, Virnig BA, Al-Refaie WB, Jarosek SL, Jensen EH, Tuttle TM. Appendiceal carcinoid tumors: predictors of lymph node metastasis and the impact of right hemicolectomy on survival. J Surg Oncol. 2011;103(1):39–45.
Google Scholar
Huang SF, Chiang CL, Lee MH. Suture granuloma mimicking local recurrence of colon cancer after open right hemicolectomy: a case report. Surg Case Rep. 2021;7(1):164.
Google Scholar
Ramser M, Kwok AMF, Maeda Y, Potter MA. Oncological and clinical outcomes after conventional right hemicolectomy. Langenbeck’s Archives Surg. 2021;406(8):2781–8.
Pramateftakis MG. Optimizing colonic cancer surgery: high ligation and complete mesocolic excision during right hemicolectomy. Tech Coloproctol. 2010;14(Suppl 1):S49–51.
Google Scholar
Kasprzak A. The role of tumor microenvironment cells in colorectal Cancer (CRC) Cachexia. Int J Mol Sci. 2021;22(4):1565.
Dieu-Nosjean MC, Giraldo NA, Kaplon H, Germain C, Fridman WH, Sautès-Fridman C. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol Rev. 2016;271(1):260–75.
Google Scholar
Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014;134(10):2403–13.
Google Scholar
Gülben K, Berberoğlu U, Öndeş B, Uyar O, Güler OC, Turanlı S. Preoperative neutrophil-to-lymphocyte ratio as a predictive factor for survival in nonmetastatic colorectal cancer. J Cancer Res Ther. 2020;16(Supplement):S189–93.
Google Scholar
Yoshida D, Minami K, Sugiyama M, Ota M, Ikebe M, Morita M, et al. Prognostic impact of the Neutrophil-to-Lymphocyte ratio in stage I-II rectal Cancer patients. J Surg Res. 2020;245:281–7.
Google Scholar
Urrejola GI, Bambs CE, Espinoza MA, Gellona J, Zúñiga AM, Molina ME, et al. [An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer]. Rev Med Chil. 2013;141(5):602–8.
Google Scholar
Verter E, Berger Y, Perl G, Peretz I, Tovar A, Morgenstern S, et al. Neutrophil-to-Lymphocyte ratio predicts recurrence pattern in patients with resectable colorectal liver metastases. Ann Surg Oncol. 2021;28(8):4320–9.
Google Scholar
Mazaki J, Katsumata K, Kasahara K, Tago T, Wada T, Kuwabara H, et al. Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis. BMC Cancer. 2020;20(1):922.
Google Scholar
Maruyama T, Shimoda M, Hakoda H, Sako A, Ueda K, Suzuki S. Preoperative prognostic nutritional index predicts risk of recurrence after curative resection for stage IIA colon cancer. Am J Surg. 2021;222(1):179–85.
Google Scholar
Peng J, Zhang R, Zhao Y, Wu X, Chen G, Wan D, et al. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer. Chin J cancer. 2017;36(1):96.
Google Scholar
Park JH, Ishizuka M, McSorley ST, Kubota K, Roxburgh CSD, Nagata H, et al. Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer. Am J Surg. 2018;216(3):458–64.
Google Scholar
Li J, Zhu N, Wang C, You L, Guo W, Yuan Z, et al. Preoperative albumin-to-globulin ratio and prognostic nutritional index predict the prognosis of colorectal cancer: a retrospective study. Sci Rep. 2023;13(1):17272.
Google Scholar
Ding P, Guo H, Sun C, Yang P, Kim NH, Tian Y, et al. Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study. BMC Gastroenterol. 2022;22(1):121.
Google Scholar
An S, Shim H, Kim K, Kim B, Bang HJ, Do H, et al. Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer. Annals Coloproctology. 2022;38(2):97–108.